Physician
Jonathan Stoever, M.D.
According to 2025 Medicare claims, Jonathan Stoever, M.D. (NPI: 1891180162) practices pulmonary disease in the Wenatchee-East Wenatchee, WA market, with the plurality of this provider's patient population coming from Douglas, WA. This provider's primary affiliated billing organization is CENTRAL WASHINGTON HEALTH SERVICES ASSOCIATION (NPI: 1881642239; TIN: 910171250) and primary practice location at 98801-3201. Stoever is affiliated with the CVS ACO (ACO ID: A5407), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.
Stoever's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 545 traditional Medicare patients, billed 2,138 HCPCS/CPT codes, and received $98,016 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,429 prescription claims across 417 beneficiaries totaling $1,198,906 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 963 claims. Open Payments data shows 1 records totaling $16. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,398 to $1,198,906. For DME billing, reported payments moved sharply higher in recent years, from $328 to $91,176.